Justice Enters Two Qui Tam Suits Over Off-label Promotion

摘要

The Justice Department is intervening in two whistle-blower suits filed against Johnson & Johnson and its Scios unit by former sales managers for allegedly promoting the heart drug Na-trecor for off-label uses.rnThe suits, which were filed in 2005, allege the defendants marketed Natrecor (nesiritide re-combinant) for serial infusions in the outpatient setting, which is not an approved indication.